J Am Acad Orthop Surg Glob Res Rev 2021 02 2;5(2). Epub 2021 Feb 2.
From the Department of Orthopedics, Mayo Clinic Arizona, Phoenix, AZ (Dr. Deckey, Dr. Lara, Dr. Hassebrock, Dr. Spangehl, and Dr. Bingham), and the Department of Orthopedics, Loma Linda Medical Center, Loma Linda, CA (Dr. Gulbrandsen).
Introduction: State legalization and widespread marketing efforts have increased the accessibility and consumption of off-label, non-FDA-approved, cannabinoid (CBD) products. Although clinical evidence is largely absent for the treatment of musculoskeletal pain, patients are experimenting with these products in efforts to relieve joint pain. Assessment of the prevalence, perceived efficacy compared with other nonsurgical modalities, and usage patterns is warranted. Read More